TRANSTHYRETIN AMYLOIDOSIS WITH CARDIOMYOPATHY
Clinical trials for TRANSTHYRETIN AMYLOIDOSIS WITH CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOIDOSIS WITH CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOIDOSIS WITH CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major heart disease trial aims to slash deaths and hospital stays
Disease control Recruiting nowThis large, late-stage study is testing whether an investigational drug called nucresiran can help people with a serious heart condition called ATTR amyloidosis cardiomyopathy. The main goal is to see if the drug reduces the risk of death and the need for urgent heart-related hos…
Matched conditions: TRANSTHYRETIN AMYLOIDOSIS WITH CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC
-
Massive global study tracks 2000 patients to map heart disease journey
Knowledge-focused Recruiting nowThis study aims to understand how patients with a serious heart condition called ATTR amyloidosis fare in everyday medical care, not just in clinical trials. Researchers will follow 2,000 patients for up to 5 years to see how treatments affect their quality of life, symptoms, and…
Matched conditions: TRANSTHYRETIN AMYLOIDOSIS WITH CARDIOMYOPATHY
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC